Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


US FDA Begins Building Pharma Industry Activity Prediction Tool

Executive Summary

Algorithms are intended to help predict incoming workload, which will be used to help set user fees.


Related Content

Generic Drugs: Machine Learning Modeling Can Better Predict ANDA Submissions
FDA May Not Implement User Fee Workload Adjuster In PDUFA VI
US FDA Wants To Predict ANDA Complete Response Responses
Want To Avoid A Refuse-To-File? Submit ANDA In English, FDA Says
Pre-IND, End-Of-Phase II Meetings Can Decrease Development Time, FDA Says





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts